205 related articles for article (PubMed ID: 27668155)
1. Experimental systems to study the origin of the myofibroblast in peritoneal fibrosis.
Padwal M; Margetts PJ
Kidney Res Clin Pract; 2016 Sep; 35(3):133-41. PubMed ID: 27668155
[TBL] [Abstract][Full Text] [Related]
2. Transition of mesothelial cell to fibroblast in peritoneal dialysis: EMT, stem cell or bystander?
Liu Y; Dong Z; Liu H; Zhu J; Liu F; Chen G
Perit Dial Int; 2015; 35(1):14-25. PubMed ID: 25700459
[TBL] [Abstract][Full Text] [Related]
3. Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia.
De Vriese AS; Tilton RG; Mortier S; Lameire NH
Nephrol Dial Transplant; 2006 Sep; 21(9):2549-55. PubMed ID: 16757496
[TBL] [Abstract][Full Text] [Related]
4. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.
Aroeira LS; Aguilera A; Sánchez-Tomero JA; Bajo MA; del Peso G; Jiménez-Heffernan JA; Selgas R; López-Cabrera M
J Am Soc Nephrol; 2007 Jul; 18(7):2004-13. PubMed ID: 17568021
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport.
Del Peso G; Jiménez-Heffernan JA; Bajo MA; Aroeira LS; Aguilera A; Fernández-Perpén A; Cirugeda A; Castro MJ; de Gracia R; Sánchez-Villanueva R; Sánchez-Tomero JA; López-Cabrera M; Selgas R
Kidney Int Suppl; 2008 Apr; (108):S26-33. PubMed ID: 18379544
[TBL] [Abstract][Full Text] [Related]
6. The origin of interstitial myofibroblasts in chronic kidney disease.
Grgic I; Duffield JS; Humphreys BD
Pediatr Nephrol; 2012 Feb; 27(2):183-93. PubMed ID: 21311912
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis.
Jiménez-Heffernan JA; Aguilera A; Aroeira LS; Lara-Pezzi E; Bajo MA; del Peso G; Ramírez M; Gamallo C; Sánchez-Tomero JA; Alvarez V; López-Cabrera M; Selgas R
Virchows Arch; 2004 Mar; 444(3):247-56. PubMed ID: 14749928
[TBL] [Abstract][Full Text] [Related]
8. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.
Liu X; Shen M; Qi Q; Zhang H; Guo SW
Hum Reprod; 2016 Apr; 31(4):734-49. PubMed ID: 26908845
[TBL] [Abstract][Full Text] [Related]
9. The John F. Maher Recipient Lecture 2004: Rage in the peritoneum.
De Vriese AS
Perit Dial Int; 2005; 25(1):8-11. PubMed ID: 15770917
[TBL] [Abstract][Full Text] [Related]
10. Cellular Changes Consistent With Epithelial-Mesenchymal Transition and Fibroblast-to-Myofibroblast Transdifferentiation in the Progression of Experimental Endometriosis in Baboons.
Zhang Q; Duan J; Olson M; Fazleabas A; Guo SW
Reprod Sci; 2016 Oct; 23(10):1409-21. PubMed ID: 27076446
[TBL] [Abstract][Full Text] [Related]
11. Olive leaf extract counteracts epithelial to mesenchymal transition process induced by peritoneal dialysis, through the inhibition of TGFβ1 signaling.
Lupinacci S; Perri A; Toteda G; Vizza D; Puoci F; Parisi OI; Giordano F; Lofaro D; La Russa A; Bonofiglio M; Bonofiglio R
Cell Biol Toxicol; 2019 Apr; 35(2):95-109. PubMed ID: 29978330
[TBL] [Abstract][Full Text] [Related]
12. Myofibroblast in Kidney Fibrosis: Origin, Activation, and Regulation.
Yuan Q; Tan RJ; Liu Y
Adv Exp Med Biol; 2019; 1165():253-283. PubMed ID: 31399969
[TBL] [Abstract][Full Text] [Related]
13. Update on mechanisms of ultrafiltration failure.
Kim YL
Perit Dial Int; 2009 Feb; 29 Suppl 2():S123-7. PubMed ID: 19270200
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of epithelial-mesenchymal transition of peritoneal mesothelial cells during peritoneal dialysis.
Lee HB; Ha H
J Korean Med Sci; 2007 Dec; 22(6):943-5. PubMed ID: 18162703
[TBL] [Abstract][Full Text] [Related]
15. Effect of human amniotic epithelial cells on pro-fibrogenic resident hepatic cells in a rat model of liver fibrosis.
Cargnoni A; Farigu S; Cotti Piccinelli E; Bonassi Signoroni P; Romele P; Vanosi G; Toschi I; Cesari V; Barros Sant'Anna L; Magatti M; Silini AR; Parolini O
J Cell Mol Med; 2018 Feb; 22(2):1202-1213. PubMed ID: 29105277
[TBL] [Abstract][Full Text] [Related]
16. Active compounds extracted from extra virgin olive oil counteract mesothelial-to-mesenchymal transition of peritoneal mesothelium cells exposed to conventional peritoneal dialysate: in vitro and in vivo evidences.
Lupinacci S; Toteda G; Vizza D; Perri A; Benincasa C; Mollica A; La Russa A; Gigliotti P; Leone F; Lofaro D; Bonofiglio M; Perri E; Bonofiglio R
J Nephrol; 2017 Dec; 30(6):841-850. PubMed ID: 27914030
[TBL] [Abstract][Full Text] [Related]
17. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
Kramann R; DiRocco DP; Humphreys BD
J Pathol; 2013 Nov; 231(3):273-89. PubMed ID: 24006178
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice.
Shen M; Liu X; Zhang H; Guo SW
Hum Reprod; 2016 Feb; 31(2):355-69. PubMed ID: 26689216
[TBL] [Abstract][Full Text] [Related]
19. Human peritoneal mesothelial cell transformation into myofibroblasts in response to TGF-ß1 in vitro.
Lv ZD; Na D; Ma XY; Zhao C; Zhao WJ; Xu HM
Int J Mol Med; 2011 Feb; 27(2):187-93. PubMed ID: 21152863
[TBL] [Abstract][Full Text] [Related]
20. Loosening of the mesothelial barrier as an early therapeutic target to preserve peritoneal function in peritoneal dialysis.
Kang DH
Kidney Res Clin Pract; 2020 Jun; 39(2):136-144. PubMed ID: 32576713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
